What is the treatment for Perinorm (metoclopramide)-associated facial palsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Metoclopramide-Associated Facial Palsy

Metoclopramide-associated facial palsy should be treated by immediately discontinuing the offending medication, followed by oral corticosteroids (prednisolone 50 mg daily for 10 days or prednisone 60 mg daily for 5 days with a 5-day taper) initiated within 72 hours of symptom onset, combined with aggressive eye protection measures. 1, 2

Immediate Management Steps

1. Discontinue Metoclopramide

  • Stop the causative agent immediately upon recognition of facial palsy, as drug-induced peripheral facial nerve palsy can resolve with discontinuation of the offending medication 3
  • Blood pressure monitoring is essential if hypertension is present, as drug-induced hypertension can contribute to facial nerve palsy 3

2. Exclude Alternative Diagnoses

  • Perform a thorough history and physical examination to exclude stroke (which spares the forehead), trauma, infection (Lyme disease, herpes zoster), tumor, or other identifiable causes before proceeding with treatment 1, 4
  • Document function of all cranial nerves to exclude central causes or cranial polyneuritis 1, 4
  • Routine laboratory testing and imaging are NOT recommended unless atypical features are present (bilateral involvement, other cranial nerve deficits, recurrence on same side, or no recovery after 3 months) 1, 2

Pharmacological Treatment

Corticosteroid Therapy (Primary Treatment)

  • Initiate oral corticosteroids within 72 hours of symptom onset for patients 16 years and older 1, 2
  • Recommended regimens:
    • Prednisolone 50 mg daily for 10 days, OR
    • Prednisone 60 mg daily for 5 days followed by 10 mg decrements daily for 5 days 1, 2, 5
  • Evidence demonstrates 83% recovery at 3 months with prednisolone versus 63.6% with placebo, and 94.4% recovery at 9 months versus 81.6% with placebo 2
  • Do NOT initiate steroids beyond 72 hours, as there is no evidence of benefit after this window 2

Antiviral Therapy Considerations

  • Do NOT prescribe antiviral monotherapy alone, as it is ineffective 1, 2
  • May consider adding oral antiviral therapy (valacyclovir or acyclovir) to corticosteroids within 72 hours if severe pain or complete paralysis is present, though the added benefit is minimal 2, 5
  • Acyclovir 400 mg orally five times daily for 10 days can be used as an alternative to valacyclovir 2

Mandatory Eye Protection Protocol

Immediate Implementation

  • Implement aggressive eye protection for all patients with impaired eye closure to prevent permanent corneal damage 1, 2

Specific Eye Protection Measures:

  • Lubricating ophthalmic drops: Apply every 1-2 hours while awake 2
  • Ophthalmic ointment: Apply at bedtime for sustained moisture retention 2
  • Eye taping or patching: Use at night with careful instruction on proper technique to avoid corneal abrasion 2
  • Sunglasses: Wear outdoors to protect against wind and foreign particles 2
  • Moisture chambers: Consider polyethylene covers for severe cases 2

Urgent Ophthalmology Referral Indications:

  • Complete inability to close the eye 2
  • Eye pain, vision changes, redness, discharge, or foreign body sensation 2
  • Signs of corneal exposure or damage 2

Follow-Up and Reassessment Algorithm

Mandatory Reassessment or Specialist Referral at:

  • 3 months after symptom onset if incomplete facial recovery persists 1, 2
  • Any point if new or worsening neurologic findings develop 1, 2
  • Any point if ocular symptoms develop 1, 2

Expected Recovery Timeline:

  • Most patients begin showing recovery within 2-3 weeks 2
  • Complete recovery typically occurs within 3-4 months 2
  • Patients with incomplete paralysis have up to 94% recovery rates 2
  • Patients with complete paralysis have approximately 70% complete recovery rates within 6 months 2

Special Considerations for Drug-Induced Facial Palsy

Key Differences from Idiopathic Bell's Palsy:

  • Drug-induced facial palsy may resolve more rapidly with discontinuation of the offending agent 3
  • Monitor for resolution of associated drug-induced hypertension if present 3
  • Consider gradual improvement as evidence that the medication was the causative factor 3

Common Pitfalls to Avoid

  • Delaying corticosteroid treatment beyond 72 hours reduces effectiveness 2
  • Using antiviral therapy alone is ineffective and delays appropriate treatment 1, 2
  • Inadequate eye protection can lead to permanent corneal damage 2
  • Failing to discontinue the causative medication may prevent resolution 3
  • Improper eye taping technique can cause corneal abrasion 2
  • Failing to refer at 3 months delays access to reconstructive options 2

Long-Term Management if Recovery Incomplete

Reconstructive Options (After 3 Months):

  • Refer to facial nerve specialist or facial plastic surgeon for evaluation 2
  • Static procedures: eyelid weights, brow lifts, static facial slings 2
  • Dynamic procedures: nerve transfers, dynamic facial slings 2
  • Tarsorrhaphy or eyelid weight implantation for persistent lagophthalmos 2

Psychological Support:

  • Screen for depression in patients with persistent paralysis 2
  • Address psychosocial dysfunction and quality of life issues 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Assessment and Management of Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria and Exclusions for Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.